Henry M, Amor M, Henry I, Ethevenot G, Allaoui M, Tricoche O, Porte J M, Touchot N
Department of Cardiology and Interventional Surgery, Polyclinique D'Essey, Essey les Nancy, France.
J Vasc Interv Radiol. 1996 May-Jun;7(3):343-50. doi: 10.1016/s1051-0443(96)72864-6.
To evaluate the long-term results of stent placement in the renal arteries.
From January 1990 to August 1994, 59 hypertensive patients underwent 64 stent placement procedures. Indications were residual stenosis after percutaneous transluminal renal angioplasty in 42 patients, restenosis in 20 patients, and acute dissection in two patients. Follow-up (mean, 14 months) was obtained in 54 patients. Six-month restenosis rates were based on results of arteriography, and even more long-term patency rates were based on duplex ultrasound.
Technical success was achieved in all patients. Major complications occurred in two patients. No minor or puncture-site complications were observed. The overall 6-month restenosis rate was 1.6% (2.9% for ostial lesions). Survival analysis with the Kaplan-Meier method showed primary and secondary patency rates of 92% +/- 3.6 and 98% +/- 1.9, respectively, at 1 year and 79% +/- 8.8 and 92% +/- 6.1, respectively, at 2 years. Seventy-six percent of hypertensive patients benefited from the procedure. However, renal function was not improved by stent placement.
Stent placement in renal arteries is a useful adjunct to percutaneous transluminal angioplasty for atherosclerotic renal-artery stenoses.
评估肾动脉支架置入术的长期效果。
1990年1月至1994年8月,59例高血压患者接受了64次支架置入手术。适应证包括42例经皮腔内肾血管成形术后残余狭窄、20例再狭窄以及2例急性夹层。54例患者获得随访(平均14个月)。6个月再狭窄率基于血管造影结果,更长时间的通畅率基于双功超声检查结果。
所有患者手术技术均获成功。2例患者出现严重并发症。未观察到轻微或穿刺部位并发症。6个月总体再狭窄率为1.6%(开口处病变为2.9%)。采用Kaplan-Meier法进行生存分析显示,1年时的一期和二期通畅率分别为92%±3.6和98%±1.9,2年时分别为79%±8.8和92%±6.1。76%的高血压患者从该手术中获益。然而,支架置入术并未改善肾功能。
对于动脉粥样硬化性肾动脉狭窄,肾动脉支架置入术是经皮腔内血管成形术的一种有用辅助手段。